CRYSTAL FORM OF (R)-N-METHYLNALTREXONE BROMIDE AND USES THEREOF

The present invention provides a new form of (R)-N-methylnaltrexone bromide, and compositions thereof, useful as a peripheral mu opiod receptor antagonist.

Saved in:
Bibliographic Details
Main Authors BOYD, Thomas, SMOLENSKAYA, Valeriya, N, AL-SHAREFFI, Kadum A, PEREZ, Julio, SHAH, Syed M
Format Patent
LanguageEnglish
French
German
Published 23.08.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides a new form of (R)-N-methylnaltrexone bromide, and compositions thereof, useful as a peripheral mu opiod receptor antagonist.
AbstractList The present invention provides a new form of (R)-N-methylnaltrexone bromide, and compositions thereof, useful as a peripheral mu opiod receptor antagonist.
Author PEREZ, Julio
AL-SHAREFFI, Kadum A
BOYD, Thomas
SMOLENSKAYA, Valeriya, N
SHAH, Syed M
Author_xml – fullname: BOYD, Thomas
– fullname: SMOLENSKAYA, Valeriya, N
– fullname: AL-SHAREFFI, Kadum A
– fullname: PEREZ, Julio
– fullname: SHAH, Syed M
BookMark eNrjYmDJy89L5WSwdw6KDA5x9FFw8w_yVfB3U9AI0tT10_V1DfGI9PFz9AkJco3w93NVcAry9_V0cVVw9HNRCA12DVYI8XANcvV342FgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BxkZmxqbmhk5GxkQoAQAn6SuR
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate KRISTALLFORM VON (R)-N-METHYLNALTREXONEBROMIDE UND VERWENDUNGEN DAVON
FORME CRISTALLINE DE BROMURE DE (R)-N-METHYLNALTREXONE ET UTILISATIONS ASSOCIÉES
ExternalDocumentID EP3263571B2
GroupedDBID EVB
ID FETCH-epo_espacenet_EP3263571B23
IEDL.DBID EVB
IngestDate Fri Jul 19 13:00:34 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP3263571B23
Notes Application Number: EP20170172002
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230823&DB=EPODOC&CC=EP&NR=3263571B2
ParticipantIDs epo_espacenet_EP3263571B2
PublicationCentury 2000
PublicationDate 20230823
PublicationDateYYYYMMDD 2023-08-23
PublicationDate_xml – month: 08
  year: 2023
  text: 20230823
  day: 23
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies Wyeth LLC (Formerly Known as Wyeth)
Progenics Pharmaceuticals, Inc
RelatedCompanies_xml – name: Wyeth LLC (Formerly Known as Wyeth)
– name: Progenics Pharmaceuticals, Inc
Score 3.4774792
Snippet The present invention provides a new form of (R)-N-methylnaltrexone bromide, and compositions thereof, useful as a peripheral mu opiod receptor antagonist.
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title CRYSTAL FORM OF (R)-N-METHYLNALTREXONE BROMIDE AND USES THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230823&DB=EPODOC&locale=&CC=EP&NR=3263571B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-L8Ig9S9KHYNf1YH8pY25QqaztqJ93TaLoO9tINV_Hf91K26Yu-HQkclyN3l7vkfgF4MA2tv-AKl7lVYoJi6rps9UXdCreXleeLvGeIbuQwMoKJ9prpWQuWu16YBif0qwFHRIsq0N7rxl-vf4pYXvO2cvPMlzi0Gvip7Unb7FhtwFckz7HZOPZiV3JdpKQosakAXTF7DnrrA3GKFjD77N0RTSnr3xHFP4XDMTKr6jNolVUHjt3dx2sdOAq3991Ibk1vcw4DN5m-pcMRwbQtJLFPHpMnOZJDlgbTUTQcpQnL4ogRJ4nDF4-RYeSRCTpLkgYsYbF_AcRnqRvIKMlsv-oZG-9lppfQrlZVeQVE4bpJucapUaLt5So3TLVQFnNLLahW0KIL3T_ZXP8zdwMnQn2iWqrSW2jXH5_lHYbbmt83ivoGfAN90Q
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbokb87INZ9GER1n2wB0LY1mXo1pFZDDyRdYyEl0Fkxn_fdgH0Rd8ubXK5Xnp3vWvvV4AHy9S7C97mKrdzkaBYhqHaXVm3EtvLTtNF2jFlN3JEzWCsv0yMSQ2Wu16YCif0qwJHFBaVCXsvK3-9_iliedXbys0zX4qhVd9nPU_ZZsdaBb6ieE6PjGIvdhXXFZRCkx6WoCtWxxHe-sCS4Lzy5PTuyKaU9e-I4p_A4UgwK8pTqOVFExru7uO1JhxF2_tuQW5Nb3MGfTeZvrFBiETaFqHYR4_Jk0rViLBgGtJByBIyiSlBThJHQ4-gAfXQWDhLxAKSkNg_B-QT5gaqkGS2X_WMjPYy4wuoF6sivwTU5oaFuc6xmQvbSzVuWlrWXsxtLcN6hrMWtP5kc_XP3D00AhaFs3BIX6_hWKpSVk41fAP18uMzvxWht-R3ldK-AYaJgL4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CRYSTAL+FORM+OF+%28R%29-N-METHYLNALTREXONE+BROMIDE+AND+USES+THEREOF&rft.inventor=BOYD%2C+Thomas&rft.inventor=SMOLENSKAYA%2C+Valeriya%2C+N&rft.inventor=AL-SHAREFFI%2C+Kadum+A&rft.inventor=PEREZ%2C+Julio&rft.inventor=SHAH%2C+Syed+M&rft.date=2023-08-23&rft.externalDBID=B2&rft.externalDocID=EP3263571B2